stockrow
Friday 6 November 2026
Export PAHC’s income statement to Excel — free account
Phibro Animal Health Corporation
PAHC Healthcare Drug Manufacturers Specialty & Generic
Phibro Animal Health Corporation’s revenue for fiscal 2026 (year ended June 2026) was $1.5 billion, up 17.1% from fiscal 2025.
- Revenue
- +6.29%
- EPS
- +12.3%
- Free cash flow
- +262.1%
- Total debt
- −1.09%
Quarter to September 2026, against a year earlier
35.54
3.89
−9.87%
Follow PAHC
Alert me
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 7 | 5 | 3 | 6 | 4 | 4 | 6 | 5 |
P/E ratio |
12.76 | 21.46 | 284.00 | 16.91 | 15.81 | 21.55 | 32.04 | 23.25 | 29.10 | 22.59 |
Altman Z-Score |
2.95 | 2.53 | 2.61 | 2.62 | 2.84 | 3.29 | 3.16 | 3.87 | 4.75 | 4.27 |
P/S ratio |
0.84 | 0.80 | 0.68 | 0.57 | 0.82 | 1.40 | 1.33 | 1.54 | 2.30 | 1.92 |
Altman Z″-Score (non-manufacturers) |
4.70 | 3.97 | 4.20 | 4.57 | 4.49 | 4.47 | 4.15 | 4.79 | 4.69 | 4.43 |
P/FCF ratio |
129.04 | 24.74 | 14.89 | 0.00 | 0.00 | 61.56 | 42.00 | 73.96 | 36.58 | 18.89 |
P/Operating CF |
52.84 | 48.64 | 24.28 | 27.42 | 492.28 | 380.74 | 274.11 | 85.88 | 186.22 | 107.87 |
Beneish M-Score |
(2.39) | (2.35) | (2.92) | (2.44) | (2.23) | (2.32) | (2.69) | (2.31) | (2.49) | (2.73) |
Dividend Safety Score |
47 | — | — | — | — | — | — | — | — | — |
P/B ratio |
3.30 | 3.62 | 2.69 | 1.96 | 2.95 | 4.90 | 5.65 | 5.92 | 10.18 | 9.69 |
Price to Tangible BV |
4.31 | 5.46 | 4.39 | 3.18 | 5.33 | 9.46 | 16.47 | 9.05 | 17.82 | 20.18 |
EV/Sales |
1.27 | 1.29 | 1.05 | 0.97 | 1.18 | 1.76 | 1.70 | 1.84 | 2.58 | 2.25 |
EV/EBITDA |
7.75 | 10.60 | 11.75 | 8.90 | 9.94 | 13.64 | 13.26 | 13.63 | 16.69 | 13.78 |
EV/Operating CF |
27.90 | 20.92 | 12.14 | 71.26 | 35.28 | 30.38 | 22.89 | 32.28 | 30.22 | 17.50 |
EV/FCF |
195.01 | 40.08 | 22.95 | (24.65) | (206.95) | 77.31 | 53.69 | 88.11 | 41.11 | 22.21 |
Quick Ratio |
1.01 | 1.04 | 1.39 | 1.39 | 1.35 | 1.46 | 1.39 | 1.56 | 1.50 | 1.57 |
Current Ratio |
2.96 | 2.76 | 2.94 | 3.33 | 2.97 | 3.04 | 2.87 | 3.02 | 2.90 | 3.14 |
Net Debt/EBITDA |
2.62 | 4.06 | 4.13 | 3.69 | 3.04 | 2.78 | 2.89 | 2.19 | 1.84 | 2.06 |
Debt/Assets |
48.81% | 52.81% | 49.69% | 48.88% | 46.47% | 46.60% | 49.36% | 44.89% | 46.51% | 50.23% |
Debt/Equity |
1.90 | 2.52 | 1.90 | 1.68 | 1.65 | 1.64 | 2.06 | 1.51 | 1.69 | 2.07 |
Asset Turnover |
1.06 | 1.11 | 1.04 | 1.03 | 1.06 | 1.03 | 1.06 | 1.18 | 1.27 | 1.24 |
Operating CF/Net income |
0.69 | 1.66 | 36.26 | 0.41 | 0.64 | 0.89 | 1.77 | 0.86 | 1.08 | 1.52 |
Capex/Depreciation |
(1.10) | (0.80) | (1.11) | (1.49) | (1.11) | (0.90) | (1.02) | (1.05) | (0.67) | (0.77) |
Interest Coverage |
4.38 | 3.19 | 2.88 | 4.69 | 6.65 | 5.81 | 5.38 | 7.07 | 8.31 | 6.57 |
| 29.72% | 17.80% | 0.90% | 11.97% | 19.63% | 25.49% | 16.60% | 27.29% | 38.61% | 53.48% | |
| 6.97% | 4.12% | 0.25% | 3.43% | 5.55% | 6.69% | 4.44% | 7.83% | 10.02% | 10.50% | |
ROIC |
11.72% | 7.45% | 5.29% | 6.64% | 8.17% | 8.71% | 8.94% | 11.29% | 14.79% | 14.99% |
Return on Tangible Assets |
10.09% | 5.54% | 0.40% | 5.39% | 9.09% | 11.11% | 7.58% | 12.10% | 16.13% | 17.22% |
Average Days of Receivables |
57.41 | 64.20 | 60.78 | 61.02 | 64.51 | 64.32 | 57.70 | 70.10 | 60.42 | 60.10 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
20.96% | 22.33% | 25.53% | 23.15% | 21.91% | 23.58% | 23.45% | 21.91% | 20.48% | 19.67% |
Intangible Assets out of Total Assets |
0.06 | 0.07 | 0.10 | 0.11 | 0.13 | 0.14 | 0.16 | 0.10 | 0.12 | 0.13 |
Share Based Compensation of Revenue |
0.11% | 0.06% | 0.05% | 0.00% | 0.00% | 0.14% | 0.28% | 0.27% | 0.04% | 0.00% |
Graham Net Nets |
(0.14) | (0.26) | (0.18) | (0.19) | (0.13) | (0.09) | (0.14) | (0.03) | (0.04) | (0.07) |
Graham Number |
22.94 | 13.74 | 2.92 | 11.27 | 13.28 | 13.33 | 9.26 | 12.79 | 12.91 | 11.88 |
Earnings Yield |
7.83% | 4.66% | 0.35% | 5.91% | 6.33% | 4.64% | 3.12% | 4.30% | 3.44% | 4.43% |
Free Cash Flow Yield |
0.77% | 4.04% | 6.72% | (6.94%) | (0.70%) | 1.62% | 2.38% | 1.35% | 2.73% | 5.29% |
Revenue per Share |
37.44 | 31.99 | 25.13 | 24.14 | 23.26 | 20.59 | 19.78 | 20.49 | 20.41 | 19.34 |
Operating CF per Share |
1.70 | 1.98 | 2.16 | 0.33 | 0.78 | 1.19 | 1.47 | 1.17 | 1.74 | 2.49 |
Capex per Share |
(1.46) | (0.95) | (1.02) | (1.28) | (0.91) | (0.72) | (0.84) | (0.74) | (0.46) | (0.53) |
Free Cash Flow per Share |
0.24 | 1.03 | 1.14 | (0.95) | (0.13) | 0.47 | 0.63 | 0.43 | 1.28 | 1.96 |
Cash per Share |
2.02 | 1.90 | 2.83 | 2.01 | 2.25 | 2.30 | 2.26 | 2.02 | 1.97 | 1.42 |
Shareholders Equity per Share |
9.51 | 7.05 | 6.34 | 6.97 | 6.48 | 5.89 | 4.65 | 5.35 | 4.60 | 3.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.51 | 7.05 | 6.34 | 6.97 | 6.48 | 5.89 | 4.65 | 5.35 | 4.60 | 3.82 |
Free Cash Flow |
9.87 | 41.83 | 46.36 | (38.48) | (5.39) | 18.99 | 25.30 | 17.28 | 51.46 | 77.51 |
Working Capital |
619.04 | 517.13 | 396.85 | 409.72 | 375.40 | 334.79 | 294.60 | 311.94 | 272.24 | 247.87 |
Capital Expenditures |
(59.09) | (38.29) | (41.24) | (51.79) | (37.04) | (29.32) | (34.04) | (29.89) | (18.55) | (20.88) |
Net Current Asset Value |
(180.26) | (264.61) | (124.55) | (103.16) | (103.02) | (103.89) | (144.06) | (44.49) | (71.26) | (108.57) |
EV/EBIT |
9.90 | 15.18 | 19.95 | 13.20 | 14.14 | 19.60 | 19.63 | 18.29 | 21.39 | 17.58 |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.02 | 0.03 |
Price to Operating Income |
6.55 | 9.37 | 12.95 | 7.72 | 9.81 | 15.61 | 15.36 | 15.35 | 19.03 | 14.95 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.13 | 0.18 | 0.18 | 0.20 | 0.21 | 0.22 | 0.20 | 0.21 | 0.21 |
Cash ROIC |
0.82% | 3.87% | 5.39% | (4.59%) | (0.69%) | 2.62% | 3.80% | 2.77% | 8.93% | 14.89% |
Accounts Receivable Turnover |
6.50 | 6.52 | 6.11 | 5.93 | 6.01 | 6.10 | 5.61 | 5.62 | 6.27 | 6.12 |
Accounts Payable Turnover |
7.57 | 8.01 | 8.84 | 8.02 | 8.01 | 8.36 | 7.80 | 8.49 | 9.50 | 8.82 |
Inventory Turnover |
2.05 | 2.52 | 2.59 | 2.53 | 2.76 | 2.72 | 2.75 | 2.99 | 3.26 | 3.14 |
Average Days of Payables |
46.21 | 56.28 | 44.33 | 39.66 | 53.12 | 44.40 | 44.39 | 47.42 | 39.26 | 40.24 |
Days of Inventory on Hand |
194.15 | 180.99 | 137.75 | 149.07 | 144.01 | 140.49 | 132.08 | 128.49 | 117.58 | 114.04 |
Average Receivables |
233.39 | 198.72 | 166.47 | 165.01 | 156.69 | 136.69 | 142.77 | 147.38 | 130.79 | 124.82 |
Average Payables |
132.76 | 111.88 | 79.71 | 84.72 | 81.98 | 67.23 | 69.64 | 66.34 | 58.20 | 58.53 |
Average Inventory |
489.65 | 355.17 | 271.74 | 268.36 | 237.74 | 206.49 | 197.49 | 188.25 | 169.70 | 164.46 |
Average Assets |
1,431.07 | 1,171.54 | 976.79 | 951.55 | 886.51 | 812.71 | 755.39 | 699.18 | 647.54 | 615.62 |
Average Common Equity |
335.58 | 271.16 | 269.58 | 272.48 | 250.49 | 213.37 | 202.11 | 200.48 | 168.06 | 120.82 |
Columns are period end dates · fundamentals updated 4 Nov 2026